+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Antithyroid Preparations Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6145615
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The antithyroid preparations market is entering a period of dynamic evolution, driven by innovation in drug development, tariff realignments, and shifts toward patient-centric endocrine care. Executives and industry leaders require a nuanced understanding of supply chain dynamics, regulatory pressures, and competitive strategy to capitalize on emerging opportunities within this space.

Market Snapshot: Antithyroid Preparations Market Trends and Outlook

The antithyroid preparations market is positioned for steady growth, underpinned by heightened demand for effective management of hyperthyroidism and related thyroid conditions. The sector is seeing significant investment in advanced drug delivery forms, strategic global manufacturing expansion, and technology-aided patient engagement. The latest research presents comprehensive analysis detailing current market size, projected CAGR, and the evolving landscape poised for continued advancement.

Scope & Segmentation

This report provides in-depth coverage and forecasts, structured by the following critical segments and categories:

  • Drug Types: Carbimazole, Methimazole, Propylthiouracil
  • Product Forms: Injectables, Liquids, Tablets (including 5 mg, 10 mg, 15 mg, 20 mg options)
  • Product Types: Branded, Generic
  • Distribution Channels: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
  • End User Categories: Clinics, Home Care, Hospitals (Private and Public)
  • Indications: Graves Disease, Toxic Nodular Goiter
  • Regional Coverage: Americas (with detailed country and state breakdown), Europe, Middle East & Africa, Asia-Pacific
  • Company Analysis: Includes Teva Pharmaceutical Industries Ltd, Viatris Inc., Sandoz International GmbH, Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Lupin Limited, Apotex Inc., Hikma Pharmaceuticals PLC, Pfizer Inc., Zydus Lifesciences Ltd

Through this segmentation, stakeholders gain actionable visibility into how innovations, pricing strategies, and localized access models shape each market segment’s growth trajectory.

Key Takeaways for Senior Decision-Makers

  • Innovation in formulation technology—spanning injectables, liquids, and tablets—continues to enhance dosing precision, tolerability, and patient adherence.
  • The surge in market competition, led by expanded access to high-quality generics, is prompting originator companies to invest in specialty product positioning and real-world evidence generation.
  • Strategic collaborations between established manufacturers and emerging biotech firms are accelerating the integration of immunomodulatory adjuncts, supporting improved remission and reduced relapse.
  • Value-based healthcare models are reshaping procurement and payer strategies, with a growing emphasis on outcome-driven data and patient quality-of-life metrics in treatment evaluation.
  • Regional market adoption patterns vary widely: North America’s integration of digital health drives remote monitoring, while Western Europe and Asia-Pacific markets prioritize rapid access and localized production to address regulatory and economic diversity.
  • Patient support programs and digital engagement platforms are emerging as essential tools for fostering adherence, education, and clinical feedback in chronic thyroid disease management.

Tariff Impact on Supply Chain and Economics

The introduction of new United States tariffs on pharmaceutical imports in 2025 has reshaped the antithyroid preparations supply chain. Manufacturers are adjusting sourcing strategies, seeking alternative suppliers and reevaluating global production to offset cost pressures. Tariff-induced increases in raw material and logistics costs affect both price negotiation with payers and operational margins. Companies with diversified footprints mitigate impact through strategic regional manufacturing and supply alliances, whereas those with limited sourcing face greater financial risk.

Methodology & Data Sources

This research integrates primary interviews with endocrinologists, pharmacists, and key market stakeholders, in addition to detailed analysis from secondary sources such as regulatory filings and peer-reviewed literature. Quantitative triangulation and thematic analysis ensure robust data validation and comprehensive insight into prescribing practices and technology adoption.

Why This Report Matters

  • Offers actionable insights into regulatory challenges, supply chain risks, and evolving therapeutic trends for antithyroid preparations.
  • Equips stakeholders with evidence-based intelligence to inform strategic product development, market access, and competitive positioning across diverse geographies.
  • Supports proactive decision-making through segmentation analysis, highlighting growth levers, risks, and optimal entry points for innovation and investment.

Conclusion: Strategic Imperatives Ahead

The antithyroid preparations market is defined by regulatory evolution, supply chain adaptation, and the increasing importance of evidence-based, patient-centric strategies. Industry leaders who invest in risk resilience and integrated technology are poised to capitalize on emerging opportunities in this complex and rapidly changing sector.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of low-dose methimazole regimens to reduce agranulocytosis risk
5.2. Increased investment in targeted drug delivery systems for enhanced thyroid uptake
5.3. Growing clinical demand for long-acting ethylthiouracil formulations to improve adherence
5.4. Expansion of generic propylthiouracil manufacturing capacities to address global supply shortages
5.5. Advancements in nanoparticle-based antithyroid delivery for reduced systemic side effects
5.6. Emergence of combination therapies integrating antithyroid agents with immunomodulators for resistant patients
5.7. Regulatory approval acceleration for novel thyroperoxidase inhibitors following positive phase III trials
5.8. Integration of digital adherence monitoring tools into antithyroid treatment protocols to boost compliance
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Antithyroid Preparations Market, by Drug Type
8.1. Introduction
8.2. Carbimazole
8.3. Methimazole
8.4. Propylthiouracil
9. Antithyroid Preparations Market, by Product Form
9.1. Introduction
9.2. Injectables
9.3. Liquids
9.4. Tablets
9.4.1. 10 Mg
9.4.2. 15 Mg
9.4.3. 20 Mg
9.4.4. 5 Mg
10. Antithyroid Preparations Market, by Product Type
10.1. Introduction
10.2. Branded
10.3. Generic
11. Antithyroid Preparations Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Antithyroid Preparations Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Home Care
12.4. Hospitals
12.4.1. Private Hospitals
12.4.2. Public Hospitals
13. Antithyroid Preparations Market, by Indication
13.1. Introduction
13.2. Graves Disease
13.3. Toxic Nodular Goiter
14. Americas Antithyroid Preparations Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Antithyroid Preparations Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Antithyroid Preparations Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Teva Pharmaceutical Industries Ltd
17.3.2. Viatris Inc.
17.3.3. Sandoz International GmbH
17.3.4. Dr. Reddy's Laboratories Ltd
17.3.5. Sun Pharmaceutical Industries Ltd
17.3.6. Lupin Limited
17.3.7. Apotex Inc.
17.3.8. Hikma Pharmaceuticals PLC
17.3.9. Pfizer Inc.
17.3.10. Zydus Lifesciences Ltd
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ANTITHYROID PREPARATIONS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ANTITHYROID PREPARATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ANTITHYROID PREPARATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ANTITHYROID PREPARATIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ANTITHYROID PREPARATIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ANTITHYROID PREPARATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ANTITHYROID PREPARATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ANTITHYROID PREPARATIONS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ANTITHYROID PREPARATIONS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. ANTITHYROID PREPARATIONS MARKET: RESEARCHAI
FIGURE 28. ANTITHYROID PREPARATIONS MARKET: RESEARCHSTATISTICS
FIGURE 29. ANTITHYROID PREPARATIONS MARKET: RESEARCHCONTACTS
FIGURE 30. ANTITHYROID PREPARATIONS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANTITHYROID PREPARATIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY CARBIMAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY CARBIMAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY METHIMAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY METHIMAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY PROPYLTHIOURACIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY PROPYLTHIOURACIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY INJECTABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY LIQUIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY 10 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY 10 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY 15 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY 15 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY 20 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY 20 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY 5 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY 5 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY GRAVES DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY GRAVES DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY TOXIC NODULAR GOITER, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ANTITHYROID PREPARATIONS MARKET SIZE, BY TOXIC NODULAR GOITER, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ANTITHYROID PREPARATIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ANTITHYROID PREPARATIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES ANTITHYROID PREPARATIONS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES ANTITHYROID PREPARATIONS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 105. CANADA ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 106. CANADA ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 107. CANADA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 108. CANADA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 109. CANADA ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 110. CANADA ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 111. CANADA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 112. CANADA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 113. CANADA ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. CANADA ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. CANADA ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. CANADA ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. CANADA ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 118. CANADA ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 119. CANADA ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 120. CANADA ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 121. MEXICO ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 122. MEXICO ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 123. MEXICO ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 124. MEXICO ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 125. MEXICO ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 126. MEXICO ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 127. MEXICO ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. MEXICO ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. MEXICO ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. MEXICO ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. MEXICO ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. MEXICO ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 134. MEXICO ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 135. MEXICO ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 136. MEXICO ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 203. GERMANY ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 204. GERMANY ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 205. GERMANY ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 206. GERMANY ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 207. GERMANY ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 208. GERMANY ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 209. GERMANY ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. GERMANY ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. GERMANY ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. GERMANY ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. GERMANY ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. GERMANY ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. GERMANY ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 216. GERMANY ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 217. GERMANY ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 218. GERMANY ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 219. FRANCE ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 220. FRANCE ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 221. FRANCE ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 222. FRANCE ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 223. FRANCE ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 224. FRANCE ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 225. FRANCE ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. FRANCE ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. FRANCE ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. FRANCE ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. FRANCE ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. FRANCE ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. FRANCE ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 232. FRANCE ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 233. FRANCE ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 234. FRANCE ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 251. ITALY ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 252. ITALY ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 253. ITALY ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 254. ITALY ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 255. ITALY ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 256. ITALY ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 257. ITALY ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 258. ITALY ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 259. ITALY ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. ITALY ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. ITALY ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. ITALY ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. ITALY ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 264. ITALY ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 265. ITALY ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 266. ITALY ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 267. SPAIN ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 268. SPAIN ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 269. SPAIN ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 270. SPAIN ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 271. SPAIN ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 272. SPAIN ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 273. SPAIN ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. SPAIN ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. SPAIN ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. SPAIN ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. SPAIN ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. SPAIN ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. SPAIN ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 280. SPAIN ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 281. SPAIN ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 282. SPAIN ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARABIA ANTITHYROID PREPARATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 328. SOUTH AFRICA ANTITHYROID PREPARATIONS MARKET SIZE, BY HOSPIT

Companies Mentioned

The companies profiled in this Antithyroid Preparations market report include:
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc.
  • Sandoz International GmbH
  • Dr. Reddy's Laboratories Ltd
  • Sun Pharmaceutical Industries Ltd
  • Lupin Limited
  • Apotex Inc.
  • Hikma Pharmaceuticals PLC
  • Pfizer Inc.
  • Zydus Lifesciences Ltd

Related Reports

Carbimazole Market - Global Forecast 2026-2032 - Product Image

Carbimazole Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Endocrinology Drugs Market Report 2025 - Product Image

Endocrinology Drugs Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Side Effects of Drugs Annual. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Volume 44 - Product Image

Side Effects of Drugs Annual. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Volume 44

  • Book
  • Global
Graves Disease Market - Global Forecast 2026-2032 - Product Image

Graves Disease Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Hashimotos Disease Global Market Report 2025 - Product Image

Hashimotos Disease Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.